| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $27.0M | — | +11.5% |
| Cost of Revenue | $3.7M | — | +6.9% |
| Gross Profit | $23.3M | — | +12.2% |
| R&D Expense | $19.8M | — | +12.7% |
| SG&A Expense | $4.7M | — | +18.5% |
| Operating Income | -$5.1M | — | -16.0% |
| Pre-tax Income | -$3.1M | — | -34.6% |
| Income Tax | $1.3M | — | +32.7% |
| Net Income | -$4.5M | — | -34.0% |
| EPS (Basic) | -$0.16 | — | -14.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $21.4M | -47.4% | +13.6% |
| Accounts Receivable | $48.9M | -1.0% | +19.7% |
| Current Assets | $280.9M | -1.4% | +29.4% |
| Total Assets | $388.2M | -0.0% | +25.2% |
| Current Liabilities | $27.4M | -4.6% | -6.0% |
| Stockholders' Equity | $338.2M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$4.9M | — | +34.0% |
| Capital Expenditures | $2.3M | — | +644.4% |
| Investing Cash Flow | -$15.8M | — | -353.6% |
| Financing Cash Flow | $1.6M | — | +14.2% |
| Free Cash Flow | -$7.2M | — | +6.7% |
| +25.7% |